scholarly journals Pilot assessment of a human extracellular matrix-based vascular graft in a rabbit model

2017 ◽  
Vol 65 (3) ◽  
pp. 839-847.e1 ◽  
Author(s):  
Salma Amensag ◽  
Leslie A. Goldberg ◽  
Kerri A. O'Malley ◽  
Demaretta S. Rush ◽  
Scott A. Berceli ◽  
...  
Author(s):  
Yanhong Zhao ◽  
Xige Zhao ◽  
Rui Zhang ◽  
Ying Huang ◽  
Yunjie Li ◽  
...  

Repair of articular cartilage defects is a challenging aspect of clinical treatment. Kartogenin (KGN), a small molecular compound, can induce the differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) into chondrocytes. Here, we constructed a scaffold based on chondrocyte extracellular matrix (CECM) and poly(lactic-co-glycolic acid) (PLGA) microspheres (MP), which can slowly release KGN, thus enhancing its efficiency. Cell adhesion, live/dead staining, and CCK-8 results indicated that the PLGA(KGN)/CECM scaffold exhibited good biocompatibility. Histological staining and quantitative analysis demonstrated the ability of the PLGA(KGN)/CECM composite scaffold to promote the differentiation of BMSCs. Macroscopic observations, histological tests, and specific marker analysis showed that the regenerated tissues possessed characteristics similar to those of normal hyaline cartilage in a rabbit model. Use of the PLGA(KGN)/CECM scaffold may mimic the regenerative microenvironment, thereby promoting chondrogenic differentiation of BMSCs in vitro and in vivo. Therefore, this innovative composite scaffold may represent a promising approach for acellular cartilage tissue engineering.


1994 ◽  
Vol 75 (4) ◽  
pp. 650-658 ◽  
Author(s):  
B H Strauss ◽  
R J Chisholm ◽  
F W Keeley ◽  
A I Gotlieb ◽  
R A Logan ◽  
...  

Author(s):  
Marie F. A. Cutiongco ◽  
Marek Kukumberg ◽  
Jonnathan L. Peneyra ◽  
Matthew S. Yeo ◽  
Jia Y. Yao ◽  
...  

2016 ◽  
Vol 25 ◽  
pp. 31-37 ◽  
Author(s):  
D.N. Coakley ◽  
F.M. Shaikh ◽  
K. O'Sullivan ◽  
E.G. Kavanagh ◽  
P.A. Grace ◽  
...  

2008 ◽  
Vol 117 (8) ◽  
pp. 598-603 ◽  
Author(s):  
Bernard Rousseau ◽  
Ping Jiang Ge ◽  
Tsunehisa Ohno ◽  
Lesley C. French ◽  
Susan L. Thibeault

2017 ◽  
Vol 6 (10) ◽  
pp. 1601333 ◽  
Author(s):  
Qi Xing ◽  
Zichen Qian ◽  
Mitchell Tahtinen ◽  
Ai Hui Yap ◽  
Keegan Yates ◽  
...  

2008 ◽  
Vol 76 (5) ◽  
pp. 1848-1857 ◽  
Author(s):  
Mary Beth Brinkman ◽  
Melanie A. McGill ◽  
Jonas Pettersson ◽  
Arthur Rogers ◽  
Petra Matějková ◽  
...  

ABSTRACT The antigenicity, structural location, and function of the predicted lipoprotein TP0136 of Treponema pallidum subsp. pallidum were investigated based on previous screening studies indicating that anti-TP0136 antibodies are present in the sera of syphilis patients and experimentally infected rabbits. Recombinant TP0136 (rTP0136) protein was purified and shown to be strongly antigenic during human and experimental rabbit infection. The TP0136 protein was exposed on the surface of the bacterial outer membrane and bound to the host extracellular matrix glycoproteins fibronectin and laminin. In addition, the TP0136 open reading frame was shown to be highly polymorphic among T. pallidum subspecies and strains at the nucleotide and amino acid levels. Finally, the ability of rTP0136 protein to act as a protective antigen to subsequent challenge with infectious T. pallidum in the rabbit model of infection was assessed. Immunization with rTP0136 delayed ulceration but did not prevent infection or the formation of lesions. These results demonstrate that TP0136 is expressed on the outer membrane of the treponeme during infection and may be involved in attachment to host extracellular matrix components.


Author(s):  
Jessica L. LoSurdo ◽  
Douglas W. Chew ◽  
Alejandro Nieponice ◽  
David A. Vorp

The primary goal of tissue engineering is to develop a biological, mechanically-robust, and anti-thrombogenic vascular graft to replace diseased or damaged tissue and organs [1]. For example, researchers have incorporated smooth muscle cells (SMCs) into extracellular matrix to provide a living, functional conduits with the intended purpose of replacing SMC-containing tubes, such as the blood vessel, urethra, esophagus, intestine, etc. Although the preferred source is autologous cells to avoid immunological rejection, adult SMCs are difficult to obtain and expand. An alternative source of autologous cells could be bone marrow derived stem cells (BMSCs), which differentiate toward mesenchymal and hematopoietic lineages [2].


2018 ◽  
Vol 38 (Suppl_1) ◽  
Author(s):  
Cindy Huynh ◽  
Ting Shih ◽  
Mauricio Contreras ◽  
David Mooney ◽  
Leena Pradhan-Nabzdyk ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document